$9.11
Cogent Biosciences is a biotechnology business based in the US. Cogent Biosciences shares (COGT) are listed on the NASDAQ and all prices are listed in US Dollars. Cogent Biosciences employs 164 staff and has a market cap (total outstanding shares value) of 0.00.
Our top picks for where to buy Cogent Biosciences stock
How to buy Cogent Biosciences stock
- Choose a stock trading platform. Use our comparison table
- Open an account. Provide your personal information and sign up.
- Fund your account. Deposit funds into your account by linking your banking information or transfer funds from another trading account.
- Search for the stock name – COGT. Search for the stock by name or ticker symbol.
- Buy the stock. Place your order. It's that simple.
Buy Cogent Biosciences stock from these online trading platforms
Compare special offers, low fees and a wide range of investment options among top trading platforms.Paid non-client promotion. Finder does not invest money with providers on this page. If a brand is a referral partner, we're paid when you click or tap through to, open an account with or provide your contact information to the provider. Partnerships are not a recommendation for you to invest with any one company. Learn more about how we make money.
Finder is not an advisor or brokerage service. Information on this page is for educational purposes only and not a recommendation to invest with any one company, trade specific stocks or fund specific investments. All editorial opinions are our own.
Cogent Biosciences stock price (NASDAQ: COGT)
Use our graph to track the performance of COGT stocks over time.Cogent Biosciences shares at a glance
Latest market close | $8.69 |
---|---|
52-week range | $3.67 - $13.36 |
50-day moving average | $8.41 |
200-day moving average | $7.14 |
Wall St. target price | $16.70 |
PE ratio | N/A |
Dividend yield | N/A (0%) |
Earnings per share (TTM) | $-2.49 |
Is it a good time to buy Cogent Biosciences stock?
The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.
Cogent Biosciences price performance over time
Historical closes compared with the close of $8.69 from 2024-07-22
1 week (2024-07-17) | -3.23% |
---|---|
1 month (2024-06-24) | -2.25% |
3 months (2024-04-24) | 32.87% |
6 months (2024-01-24) | 96.16% |
1 year (2023-07-24) | -30.59% |
---|---|
2 years (2022-07-22) | -20.42% |
3 years (2021-07-23) | 34.10% |
5 years (2019-07-24) | 8.96 |
Cogent Biosciences financials
Gross profit TTM | $-121,627,000 |
---|---|
Return on assets TTM | -38.43% |
Return on equity TTM | -65.7% |
Profit margin | 0% |
Book value | $2.09 |
Market Capitalization | $941.4 million |
TTM: trailing 12 months
Cogent Biosciences share dividends
We're not expecting Cogent Biosciences to pay a dividend over the next 12 months.
Have Cogent Biosciences's shares ever split?
Cogent Biosciences's shares were split on a 1:4 basis on 8 November 2020. So if you had owned 4 shares the day before before the split, the next day you'd have owned 1 share. This wouldn't directly have changed the overall worth of your Cogent Biosciences shares – just the quantity. However, indirectly, the new 300% higher share price could have impacted the market appetite for Cogent Biosciences shares which in turn could have impacted Cogent Biosciences's share price.
Cogent Biosciences share price volatility
Over the last 12 months, Cogent Biosciences's shares have ranged in value from as little as $3.67 up to $13.36. A popular way to gauge a stock's volatility is its "beta".
Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while Cogent Biosciences's is 0.02. This would suggest that Cogent Biosciences's shares are less volatile than average (for this exchange).
Cogent Biosciences overview
Cogent Biosciences, Inc. , a biotechnology company, focuses on developing precision therapies for genetically defined diseases. Its lead product candidate includes bezuclastinib (CGT9486), a selective tyrosine kinase inhibitor designed to target mutations within the KIT receptor tyrosine kinase, including KIT D816V KIT D816V mutation that drives systemic mastocytosis, as well as other mutations in KIT exon 17, which are found in patients with advanced gastrointestinal stromal tumors. The company has a licensing agreement with Plexxikon Inc. for the research, development, and commercialization of bezuclastinib. The company was formerly known as Unum Therapeutics Inc. and changed its name to Cogent Biosciences, Inc.
Frequently asked questions
What percentage of Cogent Biosciences is owned by insiders or institutions?Currently 0.143% of Cogent Biosciences shares are held by insiders and 117.547% by institutions. How many people work for Cogent Biosciences?
Latest data suggests 164 work at Cogent Biosciences. When does the fiscal year end for Cogent Biosciences?
Cogent Biosciences's fiscal year ends in December. Where is Cogent Biosciences based?
Cogent Biosciences's address is: 275 Wyman Street, Waltham, MA, United States, 02451 What is Cogent Biosciences's ISIN number?
Cogent Biosciences's international securities identification number is: US19240Q2012
More guides on Finder
-
Opto review 2024: $0 commission, fractional theme investing
Trade commission-free stocks and ETFs with Opto, and stay ahead by spotting emerging trends through thematic investing.
-
Best paper trading platforms to practice trading with fake money [2024]
Check out our picks of the best paper trading platforms to practice trading and investing with fake money.
-
Put options explained
Learn the basics of put options: what they are, how they work and a few examples.
-
Best broker cash sweep rates for July 2024
Check out our picks for the brokers with the best cash sweep rates on uninvested cash.
-
7 best day trading platforms of July 2024
These are the best day trading platforms, according to Finder’s comprehensive analysis.
-
Today’s best brokerage account bonuses [Signup and transfer promos]
Explore the best bonuses for opening a new brokerage account.
-
11 apps like Webull you need to consider
Looking for a discount broker like Webull that offers something different? Here are some of the top alternatives to consider.
-
How to invest in the S&P 500 in 2024
What you need to know about investing in the leading indicator for the overall US stock market.
-
7 best ways to invest $10K
Check out our 7 ideas for how to invest $10K to maximize your money.
-
5 best ETFs for 2024
Check out the best-performing ETFs so far in 2024.
Ask a question